NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 127 filers reported holding NEKTAR THERAPEUTICS in Q4 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,055 | -14.4% | 4,884,594 | -35.5% | 0.02% | -24.0% |
| Q1 2024 | $7,070 | +60.1% | 7,569,063 | -3.2% | 0.02% | +47.1% |
| Q4 2023 | $4,417 | -2.7% | 7,818,804 | +2.5% | 0.02% | -10.5% |
| Q3 2023 | $4,540 | +79.6% | 7,626,388 | +73.5% | 0.02% | +90.0% |
| Q2 2023 | $2,528 | +471.9% | 4,396,020 | +597.5% | 0.01% | +400.0% |
| Q1 2023 | $442 | +750.0% | 630,249 | +2606.6% | 0.00% | – |
| Q4 2022 | $52 | -100.0% | 23,286 | -92.7% | 0.00% | -100.0% |
| Q2 2019 | $11,351,000 | +194.8% | 319,029 | +178.3% | 0.05% | +217.6% |
| Q1 2019 | $3,851,000 | +3082.6% | 114,635 | +3017.6% | 0.02% | +1600.0% |
| Q4 2018 | $121,000 | -81.3% | 3,677 | -65.3% | 0.00% | -66.7% |
| Q3 2018 | $646,000 | – | 10,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |